InfuSystem reports mixed Q3 results
By HME News Staff
Updated 12:23 PM CST, Wed November 5, 2025
ROCHESTER HILLS, Mich. – InfuSystem Holdings reported revenues of $36.5 million for the third quarter of 2025, an increase of 3% vs. the prior year. Of that, Patient Services was $22.4 million, an increase of 8%, while device solutions was $14.1 million, a decrease of 3%. Gross profit was $20.8 million, an increase of 9%. “We continue to focus on driving value creation by prioritizing profitable growth and improving processes to lower our costs,” said CEO Carrie Lachance. “During the third quarter, we have advanced several initiatives with these goals in mind. Some of these are apparent in the current period’s results, which marked higher revenue, margins and cash flow, while others will benefit future periods.” Wound care revenue increased by 115% for the quarter, fueled in part by a new partnership with a supplier of pneumatic compression devices (PCDs) for treatment of lymphedema.
Comments